The expression of LDL receptor in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model

Histochemistry and Cell Biology

Volumn 133, Issue 6, 2010, Pages 669-676

  Ueno, Masaki ^a   Wu, Bin ^a,b   Nakagawa, Toshitaka ^a   Nagai, Yukiko ^a   Onodera, Masayuki ^a   Huang, Cheng Long ^a   Kusaka, Takashi ^a   Kanenishi, Kenji ^a   Sakamoto, Haruhiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Hypertension; LDL receptor; SHRSP

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROKE;

RATTUS;

EID: 77954540146     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-010-0705-y     Document Type: Article

References (56)

1. Abdulkarim Y, Hameed Z (2006) Is the LDL receptor involved in cortical amyloid protein clearance? Neurochem Res 31:839-847
2. Adler S, Huang H (2004) Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287:F907-F913
3. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Rev Neurosci 5:S18-S25
4. Bendayan M, Nanci A, Kan FW (1987) Effect of tissue processing on colloidal gold cytochemistry. J Histochem Cytochem 35:983-996
5. Bendayan R, Lee G, Bendayan M (2002) Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 57:365-380
6. Bendayan R, Ronaldson PT, Gingras D, Bendayan M (2006) In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 54:1159-1167
7. Cao D, Fukuchi K, Wan H, Kim H, Li L (2006) Lack of LDL receptor aggravates learning and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging 27:1632-1643
8. Ceccheli R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer VV, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP (1999) In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 36:165-178
9. Ceccheli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L (2007) Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6:650-661
10. Cirrito JR, Deane R, Fagan AM, Sprinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Hotzman DM (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285-3290 (Pubitemid 41567593)
11. Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC, El-Khoury JB (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid Wbrils. Am J Pathol 160:101-112
12. Davis CG, Elhammer A, Russell DW, Schneider WJ, Kornfeld S, Brown MS, Goldstein JL (1986) Deletion of clustered O-linked carbohydrates does not impair function of low density lipoprotein receptor in transfected Wbroblasts. J Biol Chem 261:2828-2838
13. Davis CG, van Driel IR, Russell DW, Brown MS, Goldstein JL (1987) The low density lipoprotein receptor. IdentiWcation of aminoacids in cytoplasmic domain required for rapid endocytosis. J Biol Chem 262:4075-4082
14. Deane R, Du YS, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-β peptide transport across the blood- brain barrier and accumulation in brain. Nat Med 9:907-913
15. Deane R, Wu Z, Zlokovic BV (2004) RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier. Stroke 35:2628-2631
16. Dehouck B, Dehouck MP, Fruchart JC, Cecchelli R (1994) Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol 126:465-473
17. Dehouck B, Fenart L, Dehouck MO, Pierce A, Torpier G, Cecchelli R (1997) A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 138:877-889
18. Dohgu S, Yamauchi A, Takata F, Naito M, Takahashi T, Higuchi S, Sawada Y, Kataoka Y (2004) Transforming growth factor-β1 upregulated the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol 24:491-497
19. Fryer JD, DeMattos RB, McCormick LM, O'Dell MA, Spinner ML, Bales KR, Paul SM, Sullivan PM, Parsadanian M, Bu G, Holtman DM (2005) The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J Biol Chem 280:25754-25759
20. Goldstein JL, Brown MS (1976) The LDL pathway in human Wbroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism. Curr Top Cell Regul 11:147-181
21. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ (1985) Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1:1-39
22. Hazama F, Ooshima A, Tanaka T, Tomimoto K, Okamoto K (1975) Vascular lesions in the various substrains of spontaneously hypertensive rats and the effects of chronic salt ingestion. Jpn Circ J 39:7-22
23. Herz J, Marschang P (2003) Coaxing the LDL receptor family into the fold. Cell 112:289-292
24. Huang CL, Liu D, Kameyama K, Nakashima T, Yokomise H, Ueno M, Miyake M (2004) MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23:7475-7483
25. Iwanaga Y, Ueno M, Ueki M, Huang C, Tomita S, Okamoto Y, Ogawa T, Ueda N, Maekawa N, Sakamoto H (2008) The osteopontin is increased in vessels with blood-brain barrier impairment. Neuropathol Appl Neurobiol 34:145-154
26. Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, Mason SM, Paul SM, Holtman DM (2009) Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular Aβ clearance. Neuron 64:632-644
27. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, SharomFJ, Reiner PB (2001) Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121-1128
28. Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy OM, Oppenheim JJ, Wang JM (2001) Amyloid(beta)42 activates a G-protein-coupled chemoattractant receptor, FRP-like-1. J Neurosci 21:RC123-RC127
29. Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B, Yankner BA (2000) Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci 3:460-464
30. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630
31. Newman GR, Jasani B, Williams ED (1983) A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope. Histochem J 15:543-555
32. Ohtsuki S, Watanabe Y, Hori S, Suzuki H, Bhongsatiern J, Fujiyoshi M, Kamoi M, Kamiya N, Takanaga H, Terasaki T (2004) m RNA expression of the ATP-binding cassette transporter subfamily A (ABCA) in rat and human brain capillary endothelial cells. Biol Pharm Bull 27:1437-1440
33. Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293
34. Okamoto K, Yamori Y, Nagaoka A (1974) Establishment of the stroke prone spontaneously hypertensive rat. Circ Res 34/35:143-153
35. Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Wintersperger A, Malle E, Sattler W (2002) ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem 277:42781-42789
36. Parks JK, Smith TS, Trimmer PA Jr, Bennett JP Jr, Parker WD (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem 76:1050-1056
37. Poon HF, Joshi G, Sultana R, Farr SA, Banks WA, Morley JE, Calabrese V, ButterWeld DA (2004) Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 1018:86-96
38. Ruan XZ, Varghese Z, Fernando R, Moorhead JF (1998) Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 13:1391-1397
39. Sabbatini M, Strocchi P, Vitaioli L, Amenta F (2000) The hippocampus in spontaneously hypertensive rats: a quantitative microanatomical study. Neuroscience 100:251-258
40. Sabbatini M, Catalani A, Consoli C, Marletta N, Tomassoni D, Avola R (2002) The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia. Mech Ageing Dev 123:547-559
41. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV (2007) Clearance of amyloid-β by circulating lipoprotein receptors. Nat Med 13:1029-1031
42. Schmidt AM, Stern D (2000) Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 5:430-436
43. Schmidt AM, Yan SD, Wautier J-L, Stern D (1999) Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497
44. Schnackenberg CG, Welch WJ, Wilcox CS (1998) Normalization of blood pressure, and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 32:59-64
45. Shibata M, Yamada S, Kumar M, Calero J, Bading B, Frangione D, Holtzman C, Miller C, Strickland D, Ghiso J, Zlokovic B (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499
46. Sudhof TC, Russell DW, Goldstein JL, Brown MS, Sanchez-Pescador R, Bell GI (1985) Cassette of eight exons shared by genes for LDL receptor and EGF precursor. Science 228:893-895
47. Tolleshaug H, Goldstein JL, Schneider WJ, Brown MS (1982) Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell 30:715-724
48. Ueno M, Sakamoto H, Tomimoto H, Akiguchi I, Onodera M, Huang CL, Kanenishi K (2004) Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol 107:532-538 (Pubitemid 38779704)
49. Ueno M, Nakagawa T, Huang C, Ueki M, Kusaka T, Hosomi N, Kanenishi K, Onodera M, Wu B, Sakamoto H (2009) The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Neuropathol Appl Neurobiol 35:147-155
50. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL (2000) Effect of antioxidant therapy on blood pressure, and NO synthase expression in hypertensive rats. Hypertension 36:957-964
51. Wardlaw JM, Sandercock PAG, Dennia MS, Starr J (2003) Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34:806-812
52. Wautier J-L, Zoukourian C, Chappey O, Wautier M-P, Guillausseau P-J, Cao R, Hori O, Stern D, Schmidt AM (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J Clin Invest 97:238-243
53. Wilhelmus MMM, Otte-Holler I, van Triel JJJ, Veerhuis R, Maat- Schieman MLC, Bu G, de Waal RMW, Verbeek MM (2007) Lipoprotein receptor-related protein-1 mediates amyloid-β-medi ated cell death of cerebrovascular cells. Am J Pathol 171:1989-1999
54. Yamori Y, Nagaoka A, Okamoto K (1974) Importance of genetic factors in hypertensive cerebrovascular lesions. Jpn Circ J 38:1095-1100
55. Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89:807-811
56. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201